From: Using second harmonic generation to predict patient outcome in solid tumors
Univariate analysis | Multivariate analysisa | |||||
---|---|---|---|---|---|---|
Variable | HR | 95 % CI | p | HR | 95 % CI | p |
Age | ||||||
41–55 vs 40 years | 0.49 | 0.21–1.17 | 0.108 | 0.61 | 0.25–1.52 | 0.289 |
56–70 vs 40 years | 0.57 | 0.24–1.35 | 0.204 | 0.29 | 0.09–0.95 | 0.041 |
> 70 vs 40 years | 0.33 | 0.09–1.26 | 0.105 | 0.20 | 0.04–0.95 | 0.043 |
Menopausal status | ||||||
Post- vs premenopausal | 1.14 | 0.61–2.11 | 0.686 | 2.90 | 0.99–8.49 | 0.052 |
Tumor size | ||||||
2–5 vs ≤2 cm | 1.25 | 0.66–2.37 | 0.494 | 0.56 | 0.26–1.20 | 0.137 |
> 5 vs ≤2 cm | 1.66 | 0.39–7.11 | 0.492 | 0.75 | 0.15–3.72 | 0.720 |
Tumor grade | ||||||
II vs I | 2.53 | 1.02–6.24 | 0.044 | 2.16 | 0.84–5.55 | 0.111 |
III vs I | 5.02 | 1.89–13.36 | 0.001 | 4.88 | 1.64–14.56 | 0.004 |
PgR status | ||||||
Positive vs negative | 0.51 | 0.26–1.01 | 0.055 | 0.48 | 0.23–1.01 | 0.054 |
HER2 status | ||||||
Positive vs negative | 3.15 | 1.11–8.96 | 0.031 | 3.80 | 1.18–12.20 | 0.025 |
Log of F/B ratio | 0.34 | 0.11–1.03 | 0.005 | 0.29 | 0.07–1.10 | 0.068 |